
Not to take away from our sister site, The IN VIVO Blog, but lately the OTC/nutritionals world has generated enough deals to warrant our own Deals of the Week feature.
As you'll read in the March 28 issue of "The Tan Sheet," Procter & Gamble and Teva Pharmaceutical Industries joined forces to create what could prove a monster platform for Rx-to-OTC switches and new consumer health products.
Elsewhere, Walgreens gained a strong electronic retail presence in OTC drugs and supplements with its $409 million acquisition of drugstore.com, while NBTY announced it expanded into production of liquid nutritionals with its recent purchase of Vitarich Laboratories.
Not a deal, per se, but still a big deal for pharma and supplement firms everywhere, the Supreme Court ruled unanimously that shareholders of Matrixx Initiatives could proceed with their lawsuit against the Zicam maker, which the Court says should have been more forthcoming with adverse event reports linked to its intranasal products.
"The Tan Sheet" has all these stories, plus an exclusive interview with Prestige Brands CEO Matthew Mannelly and in-depth stories on how OTCs are dealing with shifting demographics and private label competition.
[To deal with the ever-changing realities shaping the OTC and nutritionals industries, check out "The Tan Sheet." The first step to your no-obligation, complimentary issue starts here.]
TOP STORIES
P&G/Teva Joint Venture Lays Foundation For Switches, Product Launches
Procter & Gamble and Teva Pharmaceutical Industries combine their consumer businesses in a joint venture that creates a leading platform for Rx-to-OTC switches and new consumer health products.
Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden
The Supreme Court's decision in a complaint shareholders brought against Matrixx Initiatives lowers the threshold for when firms need to disclose information, but also aims to prevent an "avalanche of trivial information."
Prestige CEO Mannelly Sees Change In Retail "Headwinds" Giving Brands More Shelf Space
In a year-and-a-half of heading Prestige Brands Holdings, Matthew Mannelly has been a change agent for the consumer health products firm.